Mathias Lidgren
Director/Board Member bij REX INTERNATIONAL HOLDING LIMITED
Vermogen: 674 240 $ op 31-03-2024
Profiel
Mathias Lidgren is currently a Non-Independent Non-Executive Director at Rex International Holding Ltd.
He also holds director positions at Captiosus AB, Rotationsplast i Munka-Ljungby AB, Caithness Fastighets AB, Forvaltningsaktiebolaget Maple, Trolleholms Slott AB, Strominnate Therapeutics AB, Moroxite Holding Pte Ltd.
and is the Director & Chief Medical Officer at Moroxite T AB.
Lidgren holds a doctorate degree from Karolinska Institutet, a graduate degree from the University of Cambridge, and an undergraduate degree from the International University of Monaco.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-03-2024 | 7 000 000 ( 0.53% ) | 674 240 $ | 31-03-2024 |
Actieve functies van Mathias Lidgren
| Bedrijven | Functie | Begin |
|---|---|---|
| REX INTERNATIONAL HOLDING LIMITED | Director/Board Member | 04-05-2022 |
Rotationsplast i Munka-Ljungby AB
 Rotationsplast i Munka-Ljungby AB Miscellaneous ManufacturingProducer Manufacturing Rotationsplast i Munka-Ljungby AB is a private company that manufactures polyethylene products. The company is based in Munka-Ljungby, Sweden. | Director/Board Member | - |
| Caithness Fastighets AB | Director/Board Member | - |
| Forvaltningsaktiebolaget Maple | Director/Board Member | - |
| Trolleholms Slott AB | Director/Board Member | - |
| Captiosus AB | Director/Board Member | - |
Strominnate Therapeutics AB
 Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Director/Board Member | - |
Moroxite Holding Pte Ltd.
 Moroxite Holding Pte Ltd. Financial ConglomeratesFinance Part of Rex International Holding Ltd., Moroxite Holding Pte Ltd. functions as an investment holding Singaporean company. The private company is based in Singapore, Singapore. | Director/Board Member | - |
Moroxite T AB
 Moroxite T AB Medical SpecialtiesHealth Technology Part of Rex International Holding Ltd., Moroxite T AB is a Swedish medical-technology company that develops devices for tumor. The private company is based in Lund, Sweden. Moroxite T was acquired by Moroxite Holding Pte Ltd. from Moroxite AB on July 31, 2023 for $4.13 million. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Mathias Lidgren
| Karolinska Institutet | Doctorate Degree |
| University of Cambridge | Graduate Degree |
| International University of Monaco | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REX INTERNATIONAL HOLDING LIMITED | Energy Minerals |
| Bedrijven in privébezit | 8 |
|---|---|
| Captiosus AB | |
Rotationsplast i Munka-Ljungby AB
Rotationsplast i Munka-Ljungby AB Miscellaneous ManufacturingProducer Manufacturing Rotationsplast i Munka-Ljungby AB is a private company that manufactures polyethylene products. The company is based in Munka-Ljungby, Sweden. | Producer Manufacturing |
| Caithness Fastighets AB | |
| Forvaltningsaktiebolaget Maple | |
| Trolleholms Slott AB | |
Strominnate Therapeutics AB
Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Commercial Services |
Moroxite T AB
Moroxite T AB Medical SpecialtiesHealth Technology Part of Rex International Holding Ltd., Moroxite T AB is a Swedish medical-technology company that develops devices for tumor. The private company is based in Lund, Sweden. Moroxite T was acquired by Moroxite Holding Pte Ltd. from Moroxite AB on July 31, 2023 for $4.13 million. | Health Technology |
Moroxite Holding Pte Ltd.
Moroxite Holding Pte Ltd. Financial ConglomeratesFinance Part of Rex International Holding Ltd., Moroxite Holding Pte Ltd. functions as an investment holding Singaporean company. The private company is based in Singapore, Singapore. | Finance |
